Latest Mergers & Acquisitions and Divestments - Healthcare Sector

Get timely intelligence about mergers & acquisitions (M&A) and divestments in the healthcare sector. Maximize Revenue, Minimize Risk.

Start a Free Trial Schedule A Call

Recent Mergers & Acquisitions (M&A) Deals Data in Healthcare 

CVS acquires Medicare Advantage broker Hella Health

Deal Size: ND

Announced Date:  May 2024

According to a LinkedIn post from Hella’s chief executive officer, CVS Health has acquired startup Medicare Advantage broker Hella Health. According to CEO Rafal Walkiewicz’s post on Tuesday, the acquisition will add Hella’s range of insurance offerings and digital capabilities for seniors to CVS’ technology platform.

HTL Biotechnology acquires the Modern Meadow’s human recombinant collagen platform for beauty and biomedical applications

Deal Size: ND

Announced Date:  May 2024

HTL Biotechnology strengthens its position as a global leader in producing and developing pharmaceutical-grade biopolymers by acquiring the beauty and biomedical division of American company Modern Meadow. With this platform, within a world-class scientific research center, the company also integrates a team recognized for its cutting-edge expertise in the field.

Labcorp to acquire assets of Invitae

Deal Size: ND

Announced Date:  May 2024

Labcorp, a global leader in innovative and comprehensive laboratory services, and Invitae, a leading medical genetics company, announced that the United States Bankruptcy Court has approved Labcorp’s previously announced bid to acquire Invitae’s assets.”As a leading medical genetics company, Invitae has advanced genomics-based testing solutions across its network,” said Mark Schroeder, Executive Vice President and President of Diagnostics Laboratories

Fusion Pharmaceuticals to be Acquired by AstraZeneca

Deal Size: $2 Billion

Announced Date:  April 2024

Fusion Pharmaceuticals, a clinical-stage oncology company focused on developing next-generation radioconjugates as precision medicines, has been acquired by AstraZeneca.

Andera Partners sells Amolyt Pharma to AstraZeneca for $1.05billion

Deal Size: $1.05 Billion

Announced Date: March 2024

Paris-based private equity firm Andera Partners has agreed to sell its portfolio company, Amolyt Pharma, a global biopharmaceutical company specializing in developing therapeutic peptides for rare endocrine and related diseases, to AstraZeneca in a deal worth up to $1.05 billion.

How can you benefit from the Intellizence Mergers & Acquisitions (M&A) Dataset?

Identify Prospective Customers:

Intellizence M&A dataset provides valuable insights into healthcare companies that have recently undergone Mergers or Acquisitions. This information allows sales teams to identify potential healthcare customers who may need new products or services, are experiencing organizational changes, or are looking to expand their operations. 

Expand Cross-Selling and Upselling Opportunities:

Intellizence M&A dataset enables sales, account management, and customer success teams to identify cross-selling and upselling opportunities within their existing customer base in healthcare. By analyzing the acquisitions or divestments in their healthcare customers, they can uncover areas where additional products or services may be required and ultimately drive increased revenue from existing accounts.

Investment and Trading:

The Intellizence M&A dataset serves as a goldmine for investors and financial analysts. By analyzing historical M&A transactions in the healthcare industry, investment teams can identify trends and industry dynamics, assess market sentiment, and make better investment strategies.  

Corporate Development and Strategy:

By analyzing the Intellizence M&A dataset, corporate development and strategy professionals can better understand consolidation, emerging market trends, and competitive dynamics in the healthcare sector. This knowledge helps evaluate market gaps, identify strategic alliances, and devise plans to expand market share and diversify offerings.

Competitive Intelligence:

Intellizence M&A dataset offers timely intelligence about corporate mergers & acquisitions, divestments, and spinoffs in healthcare. By tracking these events, sales and competitive intelligence teams can gain insights into their competitors’ strategies, identify potential vulnerabilities, and differentiate themselves in the market. 

Why Subscribe to Intellizence Mergers & Acquisitions (M&A) Dataset?

AI-Powered Platform:

The Intellizence company intelligence platform is powered by cutting-edge Natural Language Processing and Machine Learning technologies that curate M&A data from multiple external sources. Every record is human-audited for data integrity.

Delivered in Near Real-time:

Intellizence monitors thousands of sources in real-time for any latest M&A announcements from various unstructured external sources and delivers merger & acquisition data in a structured format.

Comprehensive Coverage:

Intellizence curates the data from news sources, including <industry name> focused news sites, press wires, and regulatory filings to ensure comprehensive coverage. The intellizence M&A dataset covers data from healthcare and all other emerging and established industries.

Multiple Delivery Channels:

The M&A news is delivered through multiple channels – Web Platform, Email Alerts, Slack, CRM, and ChatGPT Plugin. We offer API to power your applications and models with real-time merger & acquisition news and data. 

One-Stop Data Provider for Company Signals:

In addition to Merger & Acquisition News & Data, Intellizence offers curated news on 80+ company signals and structured datasets – Startup Funding, Mergers & Acquisitions, Business Expansion, Major Hiring, CXO Appointments & Changes, and Data & Security Breaches.

More about Intellizence M&A Dataset

Subscribe to Intellizence to get the latest intelligence about healthcare companies for sales intelligence, competitive intelligence, customer intelligence, market intelligence, and risk intelligence activities.

Latest Mergers & Acquisitions (M&A) Data – Explore Other Industries

Subscribe to Intellizence